...

Repeat Prescriptions & Reviews


After careful consideration,

we have made the difficult decision to close our ADHD Prescribing service on 21st October 2025.

When this service was first established, our primary aim was to provide high-quality ADHD assessments and prescriptions to safe titration for patients awaiting shared care with their NHS GP. Over time, many patients have remained under our care for ongoing private prescriptions. However, a number of national challenges have made it increasingly difficult to continue offering this safely and sustainably.

These challenges include:

  • Widespread issues with NHS shared-care agreements, meaning that many GP practices are unable to take over prescribing responsibilities after diagnosis and titration.
  • Delays and logistical difficulties in ensuring private prescriptions are received by patients on time, particularly through postal systems.
  • The requirements of controlled drug prescriptions, meaning prescriptions are only acceptable on registered pink prescriptions in a handwritten form for patients.
  • All Prescriptions will now come from London.

Despite our best efforts to find a sustainable solution, these challenges have made it impossible to maintain a safe, timely and cost-effective prescribing service.

We will therefore be moving to prescribing through an online pharmacy, from the 21 October 2025.

The pharmacy is not connected to Fiona Project, and we do not receive any reimbursements or commission on any prescriptions. The online pharmacy system is more secure, and this will affect how you get your prescriptions.

We have chosen Signature Pharmacy in London. We send all our prescriptions to Signature Pharmacy, and they will contact patients with a payment link and then deliver medication to your door by secure and tracked delivery.

Your prescription will always be generic and not branded unless you have a valid reason for branded medication, this is to give you the best value on medication.

This change occurs on 21st October 2025

After this date, we will no longer be issuing prescriptions for ADHD medication.

If you are currently under our care for ongoing prescriptions:

  • We recommend that you begin discussions with your GP as soon as possible regarding shared care or transfer of prescribing.
  • If shared care is not possible, you may wish to seek an alternative private ADHD prescription service, and we fully support that decision, you may also choose to continue with us.
  • Patients in Scotland: There is still no direct communication on shared care, individual surgeries are posting their shared care status online. If you are seeking shared care, rather than an independent prescriber, you can contact Health Improvement Scotland on 0131 623 4300 for further advice.
  • You Must use the Online Form to request your monthly prescriptions via our site and there

is a deadline of 20th of each month. Your first request has been actioned for you. You will need to action your November prescriptions on the site, under the tab provided.

  • Thank you for allowing us to be part of your ADHD care journey. We remain deeply grateful for your understanding and patience during this period of change.

How this change in service will affect you:

Any patients accepted on to shared care will continue with us on quarterly reviews and you should book these online, those patients already on shared care are unaffected by these changes but will need to book their own quarterly reviews online.

Please find the form below.

Service Update

Fiona Project is closed and not currently providing ADHD assessment or prescribing services.

Following the resignation of our Clinical Director, and a review of our clinical governance arrangements, we have concluded that the service is unable to continue operating safely under its existing model.

The service is experiencing significant operational difficulties common to remote ADHD service models, particularly in relation to the provision of long-term prescribing without consistent shared care support from NHS Primary Care and access to face-to-face clinical monitoring. The service was not designed to provide long-term ADHD management in the absence of these arrangements.

In addition, without a Clinical Director in post, it would not be clinically appropriate or responsible to continue providing ADHD prescribing. At this time, we are unable to appoint a replacement Clinical Director, and the service will therefore remain closed.

All patients who were previously under our care have been contacted directly and supported through a managed transition of care, including guidance on referral to NHS Integrated Care Board (ICB)-commissioned services or alternative providers where appropriate.

This decision has been taken in the interests of patient safety, regulatory compliance, and good clinical. Further updates will be published on this page should the status of the service change.

Fiona Project Management Team.